Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoon-Ju Kim
Institutions:
Kyungpook National University Hospital,
Kyungpook National University,
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
Observed institutions:
Kyungpook National University Hospital,
Kyungpook National University,
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
ORCID:
0009-0002-0555-0848
Observed ORCID:
0009-0002-0555-0848
OpenAlex ID:
A5012263842
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
2023
·
Han Sun Kim
, Bo-Reum Kim
, et al.
·
Blood Advances
·
41
PDF
Characterization of the Bone Marrow Lymphoid Microenvironment and Discovery of Prognostic Immune-Related Factors in Acute Myeloid Leukemia
2024
·
Yoon-Ju Kim
, Daehun Kwag
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Anti-Leukemic Effects of CK1α Degrader As Monotherapy and in Combination with Targeted Drugs
2023
·
Bo-Reum Kim
, Hyunseok Kang
, et al.
·
Blood
·
1
PDF
Figure S8 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Data from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S6 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S4 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Supplementary Tables from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S5 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S1 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S9 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S7 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S3 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S10 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S2 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Anti-TIM-4 Monoclonal Antibody Treatment Reduces Autoreactive CD8+ T Cells and Restores Euglycemia in New-Onset Diabetic NOD Mice
2026
·
Yoon-Ju Kim
, You Hyun Jeon
, et al.
·
Biomolecules
A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
·
Cancer Research
Psoriasin, A Member Of Antimicrobial Peptides, Is Down-Regulated In Allergic Airway Epithelia
2011
·
Yoo Suk Kim
, Hyuna Song
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
18
Citation count:
45
H-index:
2
I10-index:
1
Year
Topic
Type